- Home
- NNOX vs TRDA Comparison
NNOX vs TRDA Comparison
Compare NNOX & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNOX
- TRDA
- Stock Information
- Founded
- NNOX 2011
- TRDA 2016
- Country
- NNOX Israel
- TRDA United States
- Employees
- NNOX N/A
- TRDA N/A
- Industry
- NNOX Medical Electronics
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- NNOX Health Care
- TRDA Health Care
- Exchange
- NNOX Nasdaq
- TRDA Nasdaq
- Market Cap
- NNOX 248.7M
- TRDA 233.5M
- IPO Year
- NNOX 2020
- TRDA 2021
- Fundamental
- Price
- NNOX $3.87
- TRDA $5.47
- Analyst Decision
- NNOX Strong Buy
- TRDA Strong Buy
- Analyst Count
- NNOX 2
- TRDA 3
- Target Price
- NNOX $8.50
- TRDA $25.67
- AVG Volume (30 Days)
- NNOX 1.3M
- TRDA 253.2K
- Earning Date
- NNOX 08-12-2025
- TRDA 08-06-2025
- Dividend Yield
- NNOX N/A
- TRDA N/A
- EPS Growth
- NNOX N/A
- TRDA N/A
- EPS
- NNOX N/A
- TRDA N/A
- Revenue
- NNOX $11,886,000.00
- TRDA $79,476,000.00
- Revenue This Year
- NNOX $24.12
- TRDA N/A
- Revenue Next Year
- NNOX $160.56
- TRDA N/A
- P/E Ratio
- NNOX N/A
- TRDA N/A
- Revenue Growth
- NNOX 17.36
- TRDA N/A
- 52 Week Low
- NNOX $3.75
- TRDA $4.93
- 52 Week High
- NNOX $11.00
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- NNOX 30.71
- TRDA 43.65
- Support Level
- NNOX $3.89
- TRDA $5.46
- Resistance Level
- NNOX $4.16
- TRDA $5.76
- Average True Range (ATR)
- NNOX 0.19
- TRDA 0.30
- MACD
- NNOX -0.02
- TRDA 0.06
- Stochastic Oscillator
- NNOX 3.81
- TRDA 35.48
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.